ONP-002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ONP-002, covering 2025-03-11 to 2025-03-11. Get the full timeline:
Most recent: Clinical Trial Update: A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain Injury [Phase 2]